|
|
|
|
|
The most powerful weapon against cancer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Roche’s PATHWAY HER2 Test Gains FDA Approval For HER2-Ultralow Breast Cancer
|
|
|
 |
|
|
|
Roche shared news of receiving approval from the FDA for an expanded use of its PATHWAY® anti-HER2 (4B5) test. This test can be used to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who may benefit from treatment with targeted ADC therapy.
|
|
|
|
|
|
|
|
|
|
|
TME Pharma Partners With Aimed Analytics To Advance AI-Driven Cancer Drug Development
|
|
|
 |
|
|
|
TME Pharma N.V., a biotechnology enterprise, develops TME-targeted novel treatments for cancer therapies. It has entered into collaboration with Aimed Analytics, a leading medical data analytics company. Together with Aimed Analytics, the company has shown its commitment to developing next-generation drug candidates in minimum time and resources.
|
|
|
|
|
|
|
|
|
|
|
Innate Pharma Doses First Patient In IPH4502 Cancer Therapy Trial
|
|
|
 |
|
|
|
Innate Pharma brings a ray of hope to cancer fighters with the initiation of a Phase 1 clinical trial for IPH4502, an antibody-drug conjugate (ADC) targeting advanced solid tumours with high Nectin-4 protein levels. This trial will study the safety and efficacy of IPH4502 in patients with limited treatment options who often face relapses.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
Listen to his inspiring journey as he unravels the significance of computational chemistry and molecular dynamics. In conversation, he shares insights into the applications of AI and ML in drug discovery. What’s more? He also shares his story of overcoming challenges and achieving academic success. Watch on YouTube to see how he drives innovation in Pharma to treat diseases like COVID-19 and Cancer.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
While discussing the Smart Drug Delivery System, one cannot overlook Nanoparticles. Nanoparticles are the Trojan Horse of Cancer Treatment
|
|
|
 |
|
|
|
Angelo Colombo, the CEO of Triskelis Therapeutics S.r.l, explores the applications of innovative Nanoparticles for actively targeting cancer cells and the challenges associated with it. Read this article to learn more.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The event features an impressive line-up of keynote sessions, panel discussions, and expert presentations, covering topics like sustainable packaging innovations, cold chain logistics for biologics and vaccines, and predictive analytics for mitigating supply chain risks. Keynote speakers such as Mr. Chakravarthi AVPS, Honorary Advisor to the Pharmaceutical Export Promotion Council of India, and Dr. Hemant Koshia, Commissioner of FDCA-Gujarat, will share valuable insights.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
